Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

Resources, Production Scales and Time Required for Producing RNA Vaccines for the Global Pandemic Demand

To overcome pandemics, such as COVID-19, vaccines are urgently needed at very high volumes. Here we assess the techno-economic feasibility of producing RNA vaccines for the demand associated with a global vaccination campaign. Production process performance is assessed for three messenger RNA (mRNA)...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Zoltán Kis, Cleo Kontoravdi, Robin Shattock, Nilay Shah
Format:	Article
Sprog:	English
Udgivet:	MDPI AG 2020-12-01
Serier:	Vaccines
Fag:	RNA vaccines mRNA vaccines saRNA vaccines pandemic-response vaccine production COVID-19 production process modelling
Online adgang:	https://www.mdpi.com/2076-393X/9/1/3

Lignende værker

A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague
af: Robin John Shattock, et al.
Udgivet: (2023-11-01)

Vaccines’ New Era-RNA Vaccine
af: Wenshuo Zhou, et al.
Udgivet: (2023-08-01)

The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
af: Bruna Aparecida Souza Machado, et al.
Udgivet: (2021-11-01)

Advancing mRNA technologies for therapies and vaccines: An African context
af: Dylan Kairuz, et al.
Udgivet: (2022-10-01)

Immunogenicity of stabilized HIV-1 Env trimers delivered by self-amplifying mRNA
af: Yoann Aldon, et al.
Udgivet: (2021-09-01)

Evaluation of a self-amplifying mRNA reporter vaccine in explant models of broiler chickens
af: Janne Snoeck, et al.
Udgivet: (2023-11-01)

A flexible, thermostable nanostructured lipid carrier platform for RNA vaccine delivery
af: Alana Gerhardt, et al.
Udgivet: (2022-06-01)

The Current Landscape of mRNA Vaccines Against Viruses and Cancer–A Mini Review
af: Reese Jalal Ladak, et al.
Udgivet: (2022-05-01)

In Vitro Transcribed RNA-Based Platform Vaccines: Past, Present, and Future
af: Alexey D. Perenkov, et al.
Udgivet: (2023-10-01)

Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
af: Yalan Liu, et al.
Udgivet: (2023-06-01)

Editorial: RNA vaccines for prevalent and newly emerging diseases
af: César López-Camacho, et al.
Udgivet: (2024-08-01)

A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice
af: Paul K. Kitandwe, et al.
Udgivet: (2024-09-01)

Development of mRNA rabies vaccines
af: Zixin Fang, et al.
Udgivet: (2024-12-01)

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines
af: Dylan Kairuz, et al.
Udgivet: (2023-04-01)

New Vaccine Technologies to Combat Outbreak Situations
af: Susanne Rauch, et al.
Udgivet: (2018-09-01)

Serological findings following the second and third SARS‐CoV‐2 vaccines in lung transplant recipients
af: Enikő Bárczi, et al.
Udgivet: (2022-08-01)

Advantages of Broad-Spectrum Influenza mRNA Vaccines and Their Impact on Pulmonary Influenza
af: Ziqi Cheng, et al.
Udgivet: (2024-12-01)

Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
af: Yu-Jing Fan, et al.
Udgivet: (2021-09-01)

Efficient mRNA Delivery with mRNA Lipoplexes Prepared Using a Modified Ethanol Injection Method
af: Min Tang, et al.
Udgivet: (2023-04-01)

Advances in nucleic acid-based cancer vaccines
af: Hung-Chun Liao, et al.
Udgivet: (2025-01-01)

An mRNA vaccine against rabies provides strong and durable protection in mice
af: Miao Li, et al.
Udgivet: (2023-10-01)

Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
af: Shehzad M. Iqbal, et al.
Udgivet: (2024-08-01)

Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
af: Dimitri Papukashvili, et al.
Udgivet: (2022-10-01)

Immunogenicity of HIV-1 <i>Env</i> mRNA and <i>Env-Gag</i> VLP mRNA Vaccines in Mice
af: Qi Ma, et al.
Udgivet: (2025-01-01)

RNA-based vaccines – types, strategies of delivery and overview of RNA vaccines
af: Barbara Rusinowska, et al.
Udgivet: (2022-08-01)

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape
af: Chiranjib Chakraborty, et al.
Udgivet: (2021-07-01)

Post-RNA (mRNA) Vaccination Myocarditis: CMR Features
af: Karuna M. Das, et al.
Udgivet: (2022-04-01)

Safety and immunogenicity of an mRNA-1273 vaccine booster in adolescents
af: Amparo L. Figueroa, et al.
Udgivet: (2025-12-01)

mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
af: Alireza Shariati, et al.
Udgivet: (2024-12-01)

Nucleic Acid Vaccine Platform for DENGUE and ZIKA Flaviviruses
af: Jarin Taslem Mourosi, et al.
Udgivet: (2022-05-01)

RETRACTED ARTICLE: An overview on mRNA-based vaccines to prevent monkeypox infection
af: Mohammad Natami, et al.
Udgivet: (2024-03-01)

Effectiveness of mRNA COVID-19 Vaccination on SARS-CoV-2 Infection and COVID-19 in Sicily over an Eight-Month Period
af: Emanuele Amodio, et al.
Udgivet: (2022-03-01)

Resilience in the Vaccine Supply Chain: Learning from the COVID-19 Pandemic
af: Megan Hay, et al.
Udgivet: (2025-01-01)

Concomitant administration of seasonal influenza and COVID-19 mRNA vaccines
af: Teresa Aydillo, et al.
Udgivet: (2024-12-01)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
af: Girolamo Giannotta, et al.
Udgivet: (2023-03-01)

Development and Delivery Systems of mRNA Vaccines
af: Yongjun Liang, et al.
Udgivet: (2021-07-01)

Corrigendum: Development and Delivery Systems of mRNA Vaccines
af: Yongjun Liang, et al.
Udgivet: (2021-09-01)

mRNA melanoma vaccine revolution spurred by the COVID-19 pandemic
af: Ziyang Xu, et al.
Udgivet: (2023-03-01)

Universal Flu mRNA Vaccine: Promises, Prospects, and Problems
af: Andrei A. Deviatkin, et al.
Udgivet: (2022-04-01)

The Effect of Vaccine Type and SARS-CoV-2 Lineage on Commercial SARS-CoV-2 Serologic and Pseudotype Neutralization Assays in mRNA Vaccine Recipients
af: Nicole V. Tolan, et al.
Udgivet: (2022-04-01)